# N-of-1 for Beta-Blockers in Cardiac Amyloidosis

> **NCT05019027** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Weill Medical College of Cornell University** · enrollment: 20 (estimated)

## Conditions studied

- Cardiac Amyloidosis
- Heart Diseases
- TTR Cardiac Amyloidosis

## Interventions

- **DRUG:** Beta blocker

## Key facts

- **NCT ID:** NCT05019027
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-01-31
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05019027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05019027, "N-of-1 for Beta-Blockers in Cardiac Amyloidosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05019027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*